Takeda Pharmaceutical (TAK) Total Debt: 2018-2025

  • Takeda Pharmaceutical's Total Debt fell 9.45% to $29.6 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $29.6 billion, marking a year-over-year decrease of 9.45%. This contributed to the annual value of $29.6 billion for FY2025, which is 11.75% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Total Debt stood at $29.6 billion for Q1 2025, which was down 9.45% from $32.7 billion recorded in Q1 2024.
  • In the past 5 years, Takeda Pharmaceutical's Total Debt ranged from a high of $45.9 billion in Q1 2021 and a low of $29.6 billion during Q1 2025.
  • For the 3-year period, Takeda Pharmaceutical's Total Debt averaged around $31.8 billion, with its median value being $32.7 billion (2024).
  • Data for Takeda Pharmaceutical's Total Debt shows a maximum YoY fell of 18.58% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Takeda Pharmaceutical's Total Debt stood at $45.9 billion in 2021, then decreased by 18.58% to $37.4 billion in 2022, then declined by 11.40% to $33.1 billion in 2023, then dropped by 1.35% to $32.7 billion in 2024, then decreased by 9.45% to $29.6 billion in 2025.
  • Its Total Debt was $29.6 billion in Q1 2025, compared to $32.7 billion in Q1 2024 and $33.1 billion in Q1 2023.